| 1 | response to redox state (GO:0051775) | 6.95985892 |
| 2 | short-term memory (GO:0007614) | 6.06040118 |
| 3 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 5.92859312 |
| 4 | axoneme assembly (GO:0035082) | 5.85804317 |
| 5 | prenylation (GO:0097354) | 5.78751880 |
| 6 | protein prenylation (GO:0018342) | 5.78751880 |
| 7 | thalamus development (GO:0021794) | 5.34643653 |
| 8 | L-serine metabolic process (GO:0006563) | 5.32592642 |
| 9 | negative regulation of norepinephrine secretion (GO:0010700) | 5.14112292 |
| 10 | sequestering of actin monomers (GO:0042989) | 5.12385908 |
| 11 | organ formation (GO:0048645) | 5.02299941 |
| 12 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 5.01065052 |
| 13 | histone H3-K4 trimethylation (GO:0080182) | 4.84424081 |
| 14 | fibroblast migration (GO:0010761) | 4.75430713 |
| 15 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 4.70394651 |
| 16 | renal system development (GO:0072001) | 4.59423609 |
| 17 | establishment of nucleus localization (GO:0040023) | 4.52926637 |
| 18 | regulation of transcription initiation from RNA polymerase II promoter (GO:0060260) | 4.43658856 |
| 19 | RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502) | 4.40865642 |
| 20 | protein heterotetramerization (GO:0051290) | 4.40550447 |
| 21 | protein-cofactor linkage (GO:0018065) | 4.39114461 |
| 22 | limb bud formation (GO:0060174) | 4.31249563 |
| 23 | regulation of microtubule depolymerization (GO:0031114) | 4.25067023 |
| 24 | cerebellar Purkinje cell layer development (GO:0021680) | 4.14610754 |
| 25 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 4.09720805 |
| 26 | regulation of cardioblast proliferation (GO:0003264) | 4.09720805 |
| 27 | neurotransmitter catabolic process (GO:0042135) | 3.96249062 |
| 28 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.93610769 |
| 29 | regulation of DNA-templated transcription, initiation (GO:2000142) | 3.93129953 |
| 30 | hypotonic response (GO:0006971) | 3.90089379 |
| 31 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.85527392 |
| 32 | layer formation in cerebral cortex (GO:0021819) | 3.85429963 |
| 33 | microtubule bundle formation (GO:0001578) | 3.84715610 |
| 34 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 3.81482115 |
| 35 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.74825173 |
| 36 | negative regulation of microtubule depolymerization (GO:0007026) | 3.74491930 |
| 37 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 3.72599229 |
| 38 | pancreas development (GO:0031016) | 3.68531441 |
| 39 | intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631) | 3.67455425 |
| 40 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 3.61277367 |
| 41 | positive regulation of ERBB signaling pathway (GO:1901186) | 3.55770156 |
| 42 | nonmotile primary cilium assembly (GO:0035058) | 3.55349859 |
| 43 | rRNA catabolic process (GO:0016075) | 3.50232595 |
| 44 | regulation of autophagic vacuole assembly (GO:2000785) | 3.49037915 |
| 45 | adrenergic receptor signaling pathway (GO:0071875) | 3.47642383 |
| 46 | regulation of cell proliferation involved in heart morphogenesis (GO:2000136) | 3.46490774 |
| 47 | hypothalamus development (GO:0021854) | 3.44312827 |
| 48 | lung vasculature development (GO:0060426) | 3.42951133 |
| 49 | peptidyl-lysine trimethylation (GO:0018023) | 3.37975720 |
| 50 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.37348807 |
| 51 | mechanosensory behavior (GO:0007638) | 3.37108860 |
| 52 | protein polyglutamylation (GO:0018095) | 3.37082898 |
| 53 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.34435223 |
| 54 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.33720276 |
| 55 | forebrain morphogenesis (GO:0048853) | 3.25214764 |
| 56 | artery development (GO:0060840) | 3.24687153 |
| 57 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 3.22467190 |
| 58 | negative regulation of catecholamine secretion (GO:0033604) | 3.20134949 |
| 59 | retinal ganglion cell axon guidance (GO:0031290) | 3.18680742 |
| 60 | regulation of vacuole organization (GO:0044088) | 3.15207822 |
| 61 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.11555474 |
| 62 | spinal cord motor neuron differentiation (GO:0021522) | 3.09982563 |
| 63 | regulation of female receptivity (GO:0045924) | 3.09243118 |
| 64 | heart field specification (GO:0003128) | 3.06971762 |
| 65 | secondary heart field specification (GO:0003139) | 3.06971762 |
| 66 | negative regulation of DNA biosynthetic process (GO:2000279) | 3.04680620 |
| 67 | endocardial cushion morphogenesis (GO:0003203) | 3.00711621 |
| 68 | cardiac right ventricle morphogenesis (GO:0003215) | 3.00387683 |
| 69 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.00266619 |
| 70 | otic vesicle formation (GO:0030916) | 2.99942971 |
| 71 | regulation of uterine smooth muscle contraction (GO:0070472) | 2.98763646 |
| 72 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.96415490 |
| 73 | RNA phosphodiester bond hydrolysis (GO:0090501) | 2.94985844 |
| 74 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.92351544 |
| 75 | positive regulation of dendritic spine development (GO:0060999) | 2.91087300 |
| 76 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.89135725 |
| 77 | lung-associated mesenchyme development (GO:0060484) | 2.86985244 |
| 78 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.86448271 |
| 79 | piRNA metabolic process (GO:0034587) | 2.86010927 |
| 80 | regulation of microtubule polymerization or depolymerization (GO:0031110) | 2.84834629 |
| 81 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.84398131 |
| 82 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.84398131 |
| 83 | embryonic foregut morphogenesis (GO:0048617) | 2.83018551 |
| 84 | middle ear morphogenesis (GO:0042474) | 2.81919995 |
| 85 | regulation of alternative mRNA splicing, via spliceosome (GO:0000381) | 2.81205813 |
| 86 | regulation of action potential (GO:0098900) | 2.80648265 |
| 87 | somite development (GO:0061053) | 2.80305397 |
| 88 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.78408736 |
| 89 | serine family amino acid biosynthetic process (GO:0009070) | 2.77416045 |
| 90 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.77286442 |
| 91 | mitochondrion distribution (GO:0048311) | 2.76720582 |
| 92 | respiratory chain complex IV assembly (GO:0008535) | 2.73942023 |
| 93 | thyroid gland development (GO:0030878) | 2.73460679 |
| 94 | cullin deneddylation (GO:0010388) | 2.69793885 |
| 95 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 2.69578192 |
| 96 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.69430046 |
| 97 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 2.68180883 |
| 98 | central nervous system neuron development (GO:0021954) | 2.63509271 |
| 99 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.63045344 |
| 100 | protein neddylation (GO:0045116) | 11.3638329 |
AGGF1P3 
